Clin2
NCT06768697Possibly a fitNot yet recruiting

Nasal spray boost for COVID-19 immunity

COVID - 19

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests a nasal spray that may boost your immune system against COVID-19. It's for people who had the COVID-19 vaccine at least 6 months ago and haven't had COVID-19 recently.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have received 2 or 3 doses of the COVID-19 vaccine, with your last dose at least 6 months ago.
  • You have not had COVID-19 in the past 3 months.
  • You are able to use a nasal spray and tolerate nasal rinses, saliva collection, and blood draws.
  • If you are of childbearing age, you agree to use birth control during the trial and for 6 months after.
  • You are generally healthy, with no major medical conditions or recent infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07703475Not yet recruiting· Phase 1
Nasal spray booster for covid-19 vaccine

This study tests a new nasal spray booster vaccine for COVID-19. It looks at safety and how well it boosts your immune system. If you've had your primary shots and a booster, this might help improve your protection.

New York, New York
NCT07536308Recruiting· Phase 1
Nasal COVID-19 booster vaccine safety trial

This trial tests a new nasal spray COVID-19 booster vaccine. It aims to see if the vaccine is safe and produces a strong immune response when given through the nose and inhaled, in people who have already been vaccinated.

Decatur, Georgia
NCT06667063Recruiting
Immune response study for COVID-19 and flu

This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.

Wuhan, Hubei
NCT06008860Recruiting· Phase 4
Astepro nasal spray for early COVID-19

This trial tests whether Astepro nasal spray can help people with mild or no COVID-19 symptoms recover faster. If you have tested positive and are vaccinated, you may qualify.

Chicago, Illinois
NCT06255626Recruiting· Phase 1/Phase 2
New COVID-19 booster vaccine study

This trial tests a new type of COVID-19 booster vaccine that targets a protein to help your immune system. It's for people who already had a primary vaccine series and at least one mRNA booster, with the last booster at least 6 months ago.

Créteil
NCT06821126Recruiting· Phase 1/Phase 2
Nasal spray COVID-19 vaccine booster study for healthy adults

This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.

Dijon

Hear when a new COVID-19 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.